Bodner S M, Casavant C H, McHugh T M, Stites D P
Diagn Immunol. 1985;3(3):139-44.
Assays were performed on cells from 38 consecutive malignancies for both terminal deoxynucleotidyl transferase (TdT) and common acute lymphoblastic leukemia antigen (CALLA). TdT and CALLA occurred together only on lymphoblasts from some cases of acute lymphoblastic leukemia (ALL). In other cases of ALL, chronic myelogenous leukemia (CML) in blast crisis, and acute undifferentiated leukemia (AUL), TdT was expressed, but CALLA was absent. TdT was present predominantly on cells from the lymphoid lineage as proven by special histologic stains, and CALLA marked a population with a favorable prognosis. Significant discrepancies in the expression of these two markers and the unique properties of each suggest that both markers are useful for the full characterization of specific hematologic malignancies.
对38例连续恶性肿瘤患者的细胞进行了末端脱氧核苷酸转移酶(TdT)和普通急性淋巴细胞白血病抗原(CALLA)检测。TdT和CALLA仅在部分急性淋巴细胞白血病(ALL)病例的淋巴母细胞上同时出现。在ALL的其他病例、急变期慢性粒细胞白血病(CML)和急性未分化白血病(AUL)中,TdT表达,但CALLA缺失。通过特殊组织学染色证实,TdT主要存在于淋巴系细胞上,而CALLA标记的群体预后良好。这两种标志物表达的显著差异以及各自独特的特性表明,这两种标志物均有助于全面表征特定的血液系统恶性肿瘤。